Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Gross Profit Growth (3y) (2015 - 2026)

Analysis

Iqvia Holdings (IQV) Gross Profit Growth (3y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 3.75%
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 17.49%
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -6.73%
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 4.25%
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -3.81%
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -33.42%
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 16.43%
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -8.37%
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.75%
Mar 31, 2026 2.62%
Dec 31, 2025 2.54%
Sep 30, 2025 3.43%
Jun 30, 2025 3.02%
Mar 31, 2025 1.40%
Dec 31, 2024 2.70%
Sep 30, 2024 6.59%
Jun 30, 2024 5.95%
Mar 31, 2024 5.03%
Dec 31, 2023 7.27%
Sep 30, 2023 9.93%
Jun 30, 2023 16.29%
Mar 31, 2023 10.48%
Dec 31, 2022 29.52%
Sep 30, 2022 30.14%
Jun 30, 2022 29.13%
Mar 31, 2022 30.83%
Dec 31, 2021 31.06%
Sep 30, 2021 28.29%